-
From Insight to Impact: Rethinking Pharma-Payer Partnerships to Enable Future Access in Europe
Sep 9, 2025, 16:22 PM -
A Data-Driven Framework for Rare Disease Protocol Design: Integrating Real-World Evidence, Patient Perspectives, and Regulatory Guidance
Sep 9, 2025, 16:22 PM -
Reimbursement Trends Across Global Markets in 2024
Sep 9, 2025, 16:22 PM -
Cost Utility Analysis of a Digital Peer Navigation Program for Men With Prostate Cancer
Sep 9, 2025, 16:22 PM -
Population Impact of Performing BRCA1/2 Testing to Guide Metastatic Castration-Resistant Prostate Cancer Treatment in Spain
Sep 9, 2025, 16:22 PM -
Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions
Sep 9, 2025, 16:22 PM -
Performance of Large Language Model Clinical Data Extraction by Data Domain: A Rapid Systematic Review
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis NMA of Clinical Effectiveness of Second-Line (2L+) Treatments in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
Number of Inquiries for a Second Course of Teprotumumab in the US Over Four Years
Sep 9, 2025, 16:22 PM -
HTA Life-Cycle Concepts: The Need for HTA Bodies to Grow Beyond Their Traditional Scope
Sep 9, 2025, 16:22 PM -
Clinical and Economic Benefits of Extended-Release Metformin In Prediabetes Management
Sep 9, 2025, 16:22 PM -
Navigating Uncharted Waters: Challenge of Anticipating Technologies Subject to Environmental Considerations in Future HTA
Sep 9, 2025, 16:22 PM -
Enhancing Patient Engagement in Consensus Development: Global Insights From a Targeted Review of Digital Platforms and Methods
Sep 9, 2025, 16:22 PM -
National Competent Authorities’ Experiences With Early Feasibility Study Assessment: Promoting Dialogue, Supporting Sponsors, and Fostering Shared Learning to Harmonize the EU Framework
Sep 9, 2025, 16:22 PM -
Methodology and Challenges of Network Meta-Analysis in Health Technology Assessment of Medical Devices: A Case Study of Drug-Eluting Stents
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Dimethyl Fumarate for the Treatment of Relapsing/Remitting Multiple Sclerosis in Iraq
Sep 9, 2025, 16:22 PM -
Long-Term HTA Trends in Patient Organization Submissions to the NCPE and Future Perspectives
Sep 9, 2025, 16:22 PM -
Innovative Drug Access in Portugal: An Analysis of Managed Entry Agreements Supporting Public Coverage 2014-2024
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Personalized Lifestyle Interventions in Obesity/Overweight: A Systematic Review
Sep 9, 2025, 16:22 PM -
Resource Utilization Among Patients With Epidermolysis Bullosa: Preliminary Findings From Seven European Countries
Sep 9, 2025, 16:22 PM
